Optimising preoperative risk stratification tools for prostate cancer using mpMRI.

Lars A R Reisæter1,2, Jurgen J Fütterer3, Are Losnegård4,5

  • 1Department of Radiology, Haukeland University Hospital, Jonas Liesvei, N-5021, Bergen, Norway. lars.reisaeter@helse-bergen.no.

European Radiology
|October 8, 2017
PubMed
Summary

Multiparametric MRI (mpMRI) features, including apparent diffusion coefficient (ADC) and extraprostatic extension (EPE), significantly improve risk stratification for prostate cancer (PCa) biochemical recurrence (BCR). This enhances preoperative risk estimation and treatment selection for PCa patients.

Related Concept Videos